Traws Pharma Reports Full Year 2024 Results and Business Highlights

Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data

Read more at globenewswire.com